Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study.
about
Non-invasive diagnostic imaging of colorectal liver metastasesImaging in Colorectal Cancer: Progress and Challenges for the CliniciansRelationship Between Dual-Time Point FDG PET and Immunohistochemical Parameters in Preoperative Colorectal Cancer: Preliminary Study.Surgery for colorectal liver metastases.Indian Council of Medical Research consensus document for the management of colorectal cancer.Selective Use of (18)F-Fluorodeoxyglucose-Positron Emission Tomography and Computed Tomography in the Management of Metastatic Disease from Colorectal Cancer: Results from a regional centre.Molecular alterations associated with liver metastases development in colorectal cancer patientsPredictors of early recurrence after resection of colorectal liver metastases.The role of 18FDG PET/CT in the management of colorectal liver metastases.(18)F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in the Management of Metastatic Colorectal Cancer: Are we there yet?Is Non-Contrast CT Adequate for the Evaluation of Hepatic Metastasis in Patients Who Cannot Receive Iodinated Contrast Media?Curative strategies for liver metastases from colorectal cancer: a reviewPretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method.The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus.Preoperative CT versus diffusion weighted magnetic resonance imaging of the liver in patients with rectal cancer; a prospective randomized trial.PET/CT Fusion Scan Prevents Futile Laparotomy in Early Stage Pancreatic Cancer.Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis.Photons across medicine: relating optical and nuclear imaging.Positron emission tomography/computed tomography for optimized colon cancer staging and follow up.Imaging as a surveillance tool in rectal cancer.Positron emission tomography: current status and future challenges.Optimizing resection for "responding" hepatic metastases after neoadjuvant chemotherapy.Role of FDG-PET staging in selecting the optimum patient for hepatic resection of metastatic colorectal cancer.Surgery combined with oncological treatments in liver metastases from colorectal cancer.The challenges of integrating molecular imaging into the optimization of cancer therapy.Colorectal liver metastases: state of the art imaging.Diagnostic accuracy and impact on management of (18)F-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review."Vanishing liver metastases"-A real challenge for liver surgeons.Detection of hepatic metastases using dual-time-point FDG PET/CT scans in patients with colorectal cancer.Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study.Patient selection for the surgical treatment of resectable colorectal liver metastases.The prognostic value of fluorodeoxyglucose positron emission tomography metabolic tumor volume in solitary colorectal liver metastasis.A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9.Colorectal liver metastases with extrahepatic disease--a new criteria for oncologic resection?Signet ring cell carcinoma of resectable metastatic colorectal cancer has rare surgical value.Kinetic analysis of FDG in rat liver: effect of dietary intervention on arterial and portal vein input.Rectal cancer: a reviewUpdates in Gastrointestinal Oncology - insights from the 2008 44th annual meeting of the American Society of Clinical Oncology.CT- versus coregistered FDG-PET/CT-based radiation therapy plans for conformal radiotherapy in colorectal liver metastases: a dosimetric comparison.Patient tailored resection planning in patients undergoing liver surgery for colorectal liver metastases; how and why should you do it?
P2860
Q26798428-FCDB5F81-08F1-47F5-88E8-9AA40D2774B7Q28067562-DB9DBC3A-AB4F-4AE4-A6EC-B3408A431F01Q33704285-17833278-F8ED-492E-AABA-17FDE32D87A6Q33834452-8C2A36BC-C230-446E-89D8-1DA8888C2922Q34368271-046CD93E-03AA-4EDF-9E13-E98C4F08D223Q35054062-6F42B7DD-E0EF-4BBE-BEBB-CC46CB65E088Q35125605-CB1B95E8-A50E-4BFB-9B50-F6CB5C1B7F80Q35316954-26E984A7-F72A-4F3D-A897-A0ADC4AEC1D9Q35657993-9CF9E222-AA50-4B81-9F1A-6BB0BAF7B034Q35670323-D643F647-0551-4120-B4F4-F2666423ED39Q35719878-CCF624EB-2826-4128-9D0B-62846E426273Q35776233-19F54BC6-1B29-4E5A-BD93-221A142370DAQ35819169-2A982170-A45A-46A3-8600-C6694202DAEDQ36349575-3BAC1D90-C4A7-44F4-944A-E015E21BB434Q36469607-44B0FFE7-6E79-4F00-A8A0-006E42D5131AQ36745224-AC6B25B1-DF02-4202-BF16-A32683CEDCD1Q37279302-227A4E93-960E-40CA-A43A-8CEBF09D62DAQ37389937-808A4AC6-6B75-41C3-9CB1-E2A65E730F06Q37641478-FC6FAB58-AD0C-4ADB-9ACB-93E9A84F6140Q37658819-88D945E7-5592-4C44-A513-869600CEE98BQ37766305-D274DBDF-08DB-4A71-AAA5-31A5B0EBA921Q37782046-F5119FC6-3924-4168-B5C9-53A22DE1F10AQ37821846-156A472E-A473-46C3-9D59-DAA0670A0DD0Q37863930-ACA8265B-1CAC-4FBC-8588-F202277028E8Q37871875-C4B66FE4-7310-47D4-8E66-4D455F32C69BQ38056872-15CAC8CC-6D10-425D-874E-195BD9570263Q38260616-4EACED18-3A21-4A63-9A1D-61D8C13E814EQ38267816-BF4EA33C-3303-4160-A24E-99D6C184B0F9Q38482859-DA3C6309-530C-46E4-99A8-E0A950DBA267Q38754996-DC05C050-09DB-477B-8F7F-DADE35928C7DQ38990110-F87D5596-8B3E-45FB-970E-591D5632E474Q39566044-B7DB78B3-8B4D-4EB6-B7FC-4100A2F27AEBQ39627905-D2CBC688-9C22-4F6F-8240-5A467C01F7D9Q39760344-97535913-BAC0-434C-898D-0E5529CDE68EQ40454876-51B657CC-2684-4601-B7FA-3A866D98A796Q40670149-A6B481EA-C8E4-4D01-868A-44D00FBE456EQ42555130-476C37FF-896E-4550-9E67-71E7468584EEQ43164051-BB63AE4A-B914-4E5C-850A-414C04C2E76AQ44060949-657BF15F-EF10-4649-9E83-819A5AE8A7E6Q44200029-9D852EDE-E29D-49AB-8054-8CE4E08FD142
P2860
Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Improved selection of patients ...... F-FDG PET: a randomized study.
@en
Improved selection of patients for hepatic surgery of colorectal liver metastases with
@nl
type
label
Improved selection of patients ...... F-FDG PET: a randomized study.
@en
Improved selection of patients for hepatic surgery of colorectal liver metastases with
@nl
prefLabel
Improved selection of patients ...... F-FDG PET: a randomized study.
@en
Improved selection of patients for hepatic surgery of colorectal liver metastases with
@nl
P2093
P1476
Improved selection of patients ...... F-FDG PET: a randomized study.
@en
P2093
Bastiaan Wiering
Emile F I Comans
Helena M Dekker
Joost R M van der Sijp
Koert P de Jong
Rudi M Roumen
Theo J M Ruers
Wim J G Oyen
P304
P356
10.2967/JNUMED.109.063040
P407
P577
2009-06-12T00:00:00Z